Literature DB >> 33796602

Invasive Aspergillosis After Influenza and Other Viral Respiratory Infections Among Intensive Care Unit Patients in a Commercially Insured Population in the United States, 2013-2018.

Mitsuru Toda1, Kaitlin Benedict1, Brendan R Jackson1.   

Abstract

Influenza-associated aspergillosis (IAA) is an emerging phenomenon in intensive care unit patients with severe influenza. In a large US health insurance claims database, IAA was uncommon (0.3%) during 2013-2018. The low IAA frequency likely reflects underdiagnosis and differences in medical practices or epidemiologic differences. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.

Entities:  

Keywords:  influenza; invasive aspergillosis; viral respiratory infections

Year:  2021        PMID: 33796602      PMCID: PMC7990069          DOI: 10.1093/ofid/ofab091

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   3.835


  2 in total

1.  Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019.

Authors:  Jeremy A W Gold; Andrew Revis; Stepy Thomas; Lewis Perry; Rebekah A Blakney; Taylor Chambers; Meghan L Bentz; Elizabeth L Berkow; Shawn R Lockhart; Colleen Lysen; Natalie S Nunnally; Alexander Jordan; Hilary C Kelly; Alejandro J Montero; Monica M Farley; Nora T Oliver; Stephanie M Pouch; Andrew S Webster; Brendan R Jackson; Karlyn D Beer
Journal:  Open Forum Infect Dis       Date:  2022-04-21       Impact factor: 4.423

2.  A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic.

Authors:  Berrin Er; Ahmet Görkem Er; Dolunay Gülmez; Taha Koray Şahin; Burçin Halaçlı; Gamze Durhan; Ebru Ortaç Ersoy; Alpaslan Alp; Gökhan Metan; Zeynep Saribas; Sevtap Arikan-Akdagli; Gülşen Hazırolan; Seda Banu Akıncı; Macit Arıyürek; Arzu Topeli; Ömrüm Uzun
Journal:  Mycoses       Date:  2022-05-25       Impact factor: 4.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.